ArticleInflammopharmacology2022

Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients.

Sanjay Goyal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.